ClinicalTrials.gg
RecruitingNCT07726758Updated Jul 24, 2026

The Effectiveness of Squat Exercise for Improving Pre-Sarcopenia in Order Adults

An interventional study of Squat Exercise in Sarcopenia, sponsored by Tzu Chi University. Recruiting at 1 site in Taiwan. Open to participants aged 65 Years to 100 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-07-24.

Sponsored by Tzu Chi University · Not applicable, Interventional, and Prevention

How we know

From the registry’s dates

  • Registered 3 months after the study started (first participant enrolled Mar 2026, registered Jun 2026).
  • Started Mar 2026; still recruiting 8 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
80
Allocation
Randomized
Ages
65 Years to 100 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 96 studies in Sarcopenia with a site in Taiwan — 30 open to participants now, 31 under way, none of them phase 3. Sarcopenia · Taiwan.

Planned enrollment
31st of 67
80 · median 80
Started
2026
with 9 others
No phase
63 of 96
22 open now
Primary completion
2026-12
later than 18 of 30 live
Registered
91st of 96
by date

Among the 96 studies in Sarcopenia with a site in Taiwan, this one is the 31st largest by planned enrollment of the 67 interventional ones that give a count, is one of 10 that started in 2026, is one of 63 with no phase, reaches primary completion later than 18 of the 30 other live ones, and was the 91st registered.

Sarcopenia

1,334 studies on the registry are indexed under Sarcopenia; 418 are open to participants now.

Browse Sarcopenia studies →

Open to participants now

30 of the 96 studies in Sarcopenia with a site in Taiwan are open now. Recruiting first, the newest first:

24 more — sign in →

All 30 open studies →

A study can be open while its sites in Taiwan have not opened yet or have stopped. Only those recruiting at a site in Taiwan →

Who these studies take

Of the 246 Sarcopenia studies recruiting now, 155 (63%) set no upper age limit and 32 (13%) stop at 75 or younger; 9 take children under 18; 62 take healthy volunteers.

This study: 65 Years to 100 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 96 studies in Sarcopenia with a site in Taiwan, or all of them as a file.
02

Study summary

With the growing aging population, it has been reported that approximately 10-20% of older adults have pre-sarcopenia. Pre-sarcopenia is defined as a decline in either muscle mass or muscle strength. Previous studies have indicated that squat exercise has significant effects on improving lower-extremity muscle strength and physical performance. Early intervention through resistance exercise during the pre-sarcopenia stage may increase muscle mass, enhance physical performance, and prevent progression to sarcopenia. Therefore, the purpose of this study is to investigate the effects of squat exercise on improving pre-sarcopenia among older adults. It is expected that, following the squat exercise intervention, older adults will demonstrate significant improvements in muscle mass, lower-extremity muscle strength, physical performance, and body composition, thereby alleviating pre-sarcopenia.

03

Conditions studied

  • Sarcopenia

Browse trials for

Keywords

  • sarcopenia
  • Squat
  • muscle mass
  • Pre-sarcopenia
  • Aging
04

Who can participate

Ages eligible
65 Years to 100 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Older adults aged 65 years and above who meet at least one criterion of pre-sarcopenia.
  2. Residents of Hualien.
  3. Able to read, have clear consciousness, and communicate in Mandarin.
  4. Willing to participate in this study.

Exclusion criteria

Exclusion Criteria:

  1. Individuals with disability.
  2. Individuals with psychiatric disorders or other conditions affecting cognitive function.
  3. Individuals with injuries of the knee, hip, or lumbar spine that prevent participation in squat exercise.
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Sequential assignment
Masking
Single (Participant)
Enrollment
80 participants (estimated)

Study arms

  • Experimental
    Squat Exercise

    The researcher first assists participants in completing the questionnaire and measures older adults' InBody composition, grip strength, and SPPB (Short Physical Performance Battery). A 12-week squat exercise intervention is then implemented. Post-intervention assessments are conducted at Week 6 and Week 12.

    Behavioral: Squat Exercise

  • No intervention
    Intervention: Usual Care

    No specific resistance training is performed, and participants maintain their usual daily activities.

Interventions

  • BehavioralSquat Exercise

    Squat exercise is an effective resistance training intervention that enhances lower-extremity muscle strength, physical performance, and functional ability, thereby helping prevent or delay sarcopenia in older adults.

06

What researchers measure

Primary outcomes

  1. Physical performance assessed by the Short Physical Performance Battery (SPPB)

    Physical performance will be assessed using the Short Physical Performance Battery (SPPB). The SPPB consists of three components: balance test, gait speed test, and chair stand test. Total scores range from 0 to 12 points, with higher scores indicating better physical performance

    Time frame: Baseline, 6 weeks, and 12 weeks

  2. Body composition assessed by bioelectrical impedance analysis (InBody)

    Body composition will be assessed using bioelectrical impedance analysis (InBody).Measurements include skeletal muscle mass, body fat mass, and body fat percentage.

    Time frame: Baseline, 6 weeks, and 12 weeks

07

Study locations

1 of 1 sites recruiting
  • Hsiao-Chien,Tseng
    Taipei, Taiwan
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Mar 2026 (actual). Primary completion is estimated for Dec 2026, 9 months after the start.

Of 497 non-industry interventional studies with no phase under Sarcopenia, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 34. This study's planned 9 months is below that.

Counting every sponsor, half of 509 studies reached it within 18 months; a quarter within 8 and three quarters within 34.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 27, 2026
First posted
Jul 24, 2026
StartActual
Mar 6, 2026
Primary completionEst.
Dec 31, 2026
CompletionEst.
Dec 31, 2028
Last update
Jul 24, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 24, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07726758
Lead sponsor
Tzu Chi University
Responsible party
TSENG,HSIAO-CHIEN (Principal Investigator, Tzu Chi University) — Principal investigator
First posted
Jul 24, 2026
Start date
Mar 6, 2026
Primary completion
Dec 31, 2026 (estimated)
Completion
Dec 31, 2028 (estimated)
Last update
Jul 24, 2026

Study contacts

HSIAO-CHIEN TSENG, MASTER
Contact
qq572797@gmail.com
0910861224
HSIAO-CHIEN TSENG, MASTER
study chair · STUDENT

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion